To understand whether TXNIP mediated the anti-tumor effects of JQ1, we knocked out TXNIP in HepG2 cells with two sgRNA and subsequently assessed the sensitivity of these cells to JQ1. The gene discussed is TXNIP; the disease is neoplasm.